CoMentis Lands $20,000,000 New Funding

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    280 Utah Avenue South San Francisco, CA 94080
  • Company Description
    CoMentis is engaged in the discovery and development of small-molecule drugs to treat neurovascular disease such as Alzheimer’s disease, AMD and cognitive disorders.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Clarus Ventures
  • Venture Investor
    Index Ventures
  • Venture Investor
    Sanderling Ventures
  • Venture Investor

Trending on Xconomy